1096 related articles for article (PubMed ID: 27774992)
1. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
2. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
Qu Y; Zhang L; Kang Z; Jiang W; Lv C
Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
[TBL] [Abstract][Full Text] [Related]
3. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
4. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
[TBL] [Abstract][Full Text] [Related]
5. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
6. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
11. Emodin suppresses TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells through Notch signaling pathway.
Gao R; Chen R; Cao Y; Wang Y; Song K; Zhang Y; Yang J
Toxicol Appl Pharmacol; 2017 Mar; 318():1-7. PubMed ID: 27989784
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation.
Wang T; Liu Y; Zou JF; Cheng ZS
PLoS One; 2017; 12(9):e0183972. PubMed ID: 28873461
[TBL] [Abstract][Full Text] [Related]
14. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
[TBL] [Abstract][Full Text] [Related]
15. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Han Q; Lin L; Zhao B; Wang N; Liu X
Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
20. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
